Select Medical Holdings Corporation Financial Ratios — SEM

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	37.57	52.08	41.23	37.85	34.38	28.62	48.43	40.52	49.45	62.16	70.15	27.07	36.53	28.12	18.19
Return on Assets (%)	3.93	5.36	4.1	4.2	3.58	2.48	3.53	2.49	2.23	3.45	5.36	2.12	3.17	3.22	2.55
Return on Capital (%)	9.37	11.49	8.99	8.93	8.24	7.33	- -	7.13	5.71	5.46	7.33	3.31	5.34	4.85	4.36
Return on Invested Capital (%)	10.03	10.79	9.52	9.12	7.84	6.07	- -	8	7.41	7.39	9.23	1.2	3.34	3.69	5.5
Gross Margin (%)	17.68	17.14	16.14	15.75	14.19	13.09	14.43	14.57	14.91	14.85	14.82	8.71	11.84	12.22	11.54
EBITDA Margin (%)	15.46	14.89	13.55	12.97	11.73	10.56	11.82	12.18	12.55	13.98	14.77	7.61	9.86	9.1	8.74
Operating Margin (%)	12.91	12.75	11.39	10.74	8.93	7.11	8.15	8.21	8.65	10.26	11.5	3.14	5.54	5.17	6.17
Incremental Operating Margin (%)	20.47	9.59	-138.89	-10.95	0.75	-7.23	37.91	8.58	14.65	123.12	21.72	35.67	56.5	0.3	25.54
Pretax Margin (%)	6.55	8.26	6.65	6.65	5.57	4.29	4.64	4.64	4.85	8.25	10.15	0.77	2.9	3.37	5
Profit Margin (%)	3.85	5.03	3.84	3.94	3.49	2.74	4.06	2.71	2.72	4.68	6.48	3.45	5.05	4.13	2.68
Net Income to Common Margin (%)	3.85	5.03	3.84	3.94	3.49	2.74	4.06	2.71	2.72	4.68	6.48	3.45	5.05	4.13	2.68
Effective Tax Rate (%)	38.63	36.81	37.81	37.11	34.75	30.69	- -	24.88	24.07	24.51	20.61	47.42	20.94	25.62	21.34
Dvd Payout Ratio (%)	- -	132.17	31.88	39.32	9.29	- -	- -	- -	- -	- -	8.47	112.18	38.33	30.39	11.11
Sustainable Growth Rate (%)	37.57	-16.76	28.09	22.97	31.18	28.62	48.43	40.52	49.45	62.16	64.21	-3.3	22.53	19.58	16.17

Credit (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	1,413	1,488	1,458	1,575	2,415	2,738	2,729	3,318	4,506	4,498	4,762	5,157	4,525	2,704	2,869
ST Debt	27	29	30	33	254	53	52	69	233	233	289	313	272	226	229
LT Debt	1,386	1,459	1,428	1,542	2,161	2,685	2,678	3,250	4,273	4,265	4,473	4,844	4,253	2,479	2,639
Total Debt/EBITDA	3.26	3.39	3.62	3.96	5.5	6.15	5.29	5.36	6.58	5.82	5.2	14.71	9.51	5.73	6.02
Net Debt/EBITDA	3.23	3.3	3.6	3.95	5.47	5.93	5.05	5.08	4.54	3.65	3.87	10.88	7.63	3.55	3.82
Total Debt/EBIT	3.9	3.96	4.3	4.79	7.23	9.13	7.67	7.95	9.55	7.92	6.67	35.62	16.93	10.08	8.53
Net Debt/EBIT	3.87	3.85	4.29	4.78	7.18	8.8	7.33	7.53	6.59	4.98	4.96	26.35	13.59	6.25	5.41
EBITDA to Interest Expense	4.37	4.63	4.62	4.65	3.89	2.62	3.33	3.12	3.41	5.05	6.74	2.55	3.09	3.67	4.04
EBITDA-CapEx/Interest Expense	3.91	3.91	3.77	3.54	2.27	1.67	1.83	2.28	2.63	4.1	5.41	1.17	1.6	1.94	2.1
EBIT to Interest Expense	3.65	3.96	3.88	3.85	2.96	1.76	2.3	2.1	2.35	3.71	5.25	1.05	1.73	2.09	2.85
Interest Expense	99	95	87	85	113	170	155	198	201	153	136	137	154	129	118
Common Equity/Total Assets	11.75	8.81	11.06	11.14	9.91	7.56	7.02	5.37	3.81	7.23	8.06	7.58	9.78	13.74	14.31
Long-Term Debt/Equity (%)	163.76	195.66	174.4	198.92	237.83	296.43	287.12	354.66	459.92	258.29	327.7	348.31	270.2	124.11	129.65
Long-Term Debt/Capital (%)	78.48	82.88	79.24	79.64	74.55	83.91	83.72	86.6	86.43	75.59	79.72	80.64	76.46	65.39	65.39
Long-Term Debt/Total Assets (%)	50	52.82	50.67	52.72	49.23	54.57	52.23	54.48	58.21	55.71	60.77	63.19	55.31	44.2	45.1
Total Debt/Equity (%)	167	199.61	178.07	203.13	265.76	302.28	292.66	362.18	485.01	272.41	348.89	370.82	287.45	135.41	140.92
Total Debt/Capital (%)	80.04	84.56	80.91	81.33	83.3	85.56	85.33	88.44	91.14	79.72	84.88	85.85	81.34	71.35	71.08
Total Debt/Total Assets (%)	50.99	53.89	51.74	53.84	55.02	55.65	53.23	55.64	61.39	58.75	64.7	67.27	58.84	48.22	49.02
Net Debt to Equity	165.58	194.23	177.55	202.69	264.18	291.35	279.52	343.06	334.67	171.09	259.5	274.24	230.68	84.02	89.33
Net Debt/Capital (%)	79.9	84.2	80.87	81.3	83.22	85.1	84.75	87.88	67.47	55.78	63.98	64.54	65.9	44.98	45.35
EBITDA	434	439	403	397	439	445	516	619	684	773	916	351	476	472	476
EBITDA-CapEx	388	371	330	302	257	284	283	452	527	627	736	160	247	250	247
Operating Income (Loss)	362	376	339	329	334	300	356	417	472	568	714	145	267	268	336

Liquidity (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	0.03	0.11	0.01	0.01	0.02	0.17	0.2	0.25	0.37	0.4	0.06	0.15	0.09	0.06	0.03
Current Ratio	1.26	1.22	1.22	1.34	1.03	1.33	1.52	1.41	1.33	1.11	0.9	1.1	1.01	1.04	1.04
Quick Ratio	1.11	1.07	1.06	1.13	0.85	1.18	1.35	1.25	1.2	1.02	0.76	0.96	0.67	0.9	0.9
CFO/Avg Current Liab	0.49	0.79	0.52	0.45	0.37	0.53	0.4	0.75	0.55	0.87	0.3	0.23	0.48	0.47	0.35
Common Equity/Total Assets	11.75	8.81	11.06	11.14	9.91	7.56	7.02	5.37	3.81	7.23	8.06	7.58	9.78	13.74	14.31
Long-Term Debt/Equity (%)	163.76	195.66	174.4	198.92	237.83	296.43	287.12	354.66	459.92	258.29	327.7	348.31	270.2	124.11	129.65
Long-Term Debt/Capital (%)	78.48	82.88	79.24	79.64	74.55	83.91	83.72	86.6	86.43	75.59	79.72	80.64	76.46	65.39	65.39
Long-Term Debt/Total Assets (%)	50	52.82	50.67	52.72	49.23	54.57	52.23	54.48	58.21	55.71	60.77	63.19	55.31	44.2	45.1
Total Debt/Equity (%)	167	199.61	178.07	203.13	265.76	302.28	292.66	362.18	485.01	272.41	348.89	370.82	287.45	135.41	140.92
Total Debt/Capital (%)	80.04	84.56	80.91	81.33	83.3	85.56	85.33	88.44	91.14	79.72	84.88	85.85	81.34	71.35	71.08
Total Debt/Total Assets (%)	50.99	53.89	51.74	53.84	55.02	55.65	53.23	55.64	61.39	58.75	64.7	67.27	58.84	48.22	49.02
CFO/Total Liabilities	11.27	14.82	9.63	7.94	5.99	8.63	5.68	9.79	6.94	17.12	6.69	4.54	9.52	14.34	9.08
CFO/CapEx	4.72	4.38	2.61	1.79	1.14	2.14	1.02	2.95	2.83	7.02	2.22	1.5	2.54	2.33	1.51
Altman's Z-Score	4.5	4.62	4.45	4.22	3.26	3.39	3.36	3.42	2.35	2.34	2.82	1.73	1.43	2.66	2.58

Working Capital (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	7.31	7.62	7.92	7.34	7.14	7.16	6.9	7.27	7.42	6.67	6.95	5.04	5.8	6.71	6.47
Days Sales Outstanding	49.92	47.88	46.07	49.75	51.09	50.95	52.91	50.23	49.17	54.75	52.54	72.48	62.98	54.38	56.41
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	27.19	26.39	28.07	26.24	26.12	27.77	29.33	31.58	31.74	29.18	25.72	20.01	24.98	30.76	32.24
Accounts Payable Turnover Days	13.42	13.83	13.01	13.91	13.98	13.14	12.45	11.56	11.5	12.51	14.19	18.24	14.61	11.87	11.32
Cash Conversion Cycle	36.5	34.05	33.07	35.84	37.12	37.8	40.46	38.67	37.67	42.24	38.35	54.24	48.37	42.51	45.09
Inventory to Cash Days	49.92	47.88	46.07	49.75	51.09	50.95	52.91	50.23	49.17	54.75	52.54	72.48	62.98	54.38	56.41
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	688	705	855	1,001	817	913	1,226	1,119	1,689	1,934	2,062	1,638	1,559	2,349	1,821
- Cash & Cash Equivalents	12	40	4	3	14	99	123	175	336	577	74	98	53	60	27
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	27	28	32	36	49	90	109	113	158	591	255	269	286	316	330
+ Total Debt	1,413	1,488	1,458	1,575	2,415	2,738	2,729	3,318	4,506	4,498	4,762	5,157	4,525	2,704	2,869
Enterprise Value	2,116	2,181	2,341	2,608	3,266	3,642	3,942	4,375	6,017	6,445	7,005	6,891	6,257	5,309	4,994
Total Capital	1,766	1,760	1,802	1,936	2,899	3,200	3,198	3,752	4,944	5,642	5,611	6,007	5,562	3,790	4,036
Total Debt/Capital (%)	80.04	84.56	80.91	81.33	83.3	85.56	85.33	88.44	91.14	79.72	84.88	85.85	81.34	71.35	71.08
Total Debt / EV	0.67	0.68	0.62	0.6	0.74	0.75	0.69	0.76	0.75	0.7	0.68	0.75	0.72	0.51	0.57
EV/Sales	0.75	0.74	0.79	0.85	0.87	0.86	0.9	0.86	1.1	1.17	1.13	1.49	1.3	1.02	0.92
EV/EBITDA	4.88	4.97	5.81	6.56	7.44	8.18	7.64	7.07	8.79	8.33	7.64	19.65	13.15	11.24	10.48
EV/EBIT	5.84	5.8	6.91	7.93	9.78	12.15	11.08	10.48	12.75	11.35	9.81	47.6	23.41	19.79	14.85
EV/Cash Flow to Firm	7.61	6.08	9.48	11.62	11.58	7.84	9.69	6.8	10.07	5.64	13.76	19.3	8.89	8.65	11.37
EV/Free Cash Flow to Firm	6.53	5.11	7.31	8.16	7.03	5.82	6.16	5.4	7.97	5	10.16	12.59	6.71	6.35	7.47
Diluted Market Cap	689	706	857	1,005	819	914	1,228	1,119	1,689	1,934	2,062	1,638	1,559	2,349	1,821
Diluted Enterprise Value	2,117	2,183	2,342	2,612	3,268	3,643	3,944	4,375	6,017	6,445	7,005	6,965	6,316	5,309	4,994
EV per Share	14.06	15.72	17.11	20.22	25.62	28.5	30.57	32.34	44.79	49.66	53.78	56.24	50.83	42.61	40.72
TTM Sales	2,805	2,949	2,976	3,065	3,743	4,217	4,365	5,081	5,454	5,532	6,205	4,609	4,826	5,187	5,453
TTM EBITDA	434	439	403	397	439	445	516	619	684	773	916	351	476	472	476
TTM Operating Income	362	376	339	329	334	300	356	417	472	568	714	145	267	268	336
TTM Cash Flow to Firm	278	359	247	224	282	464	407	643	597	1,144	509	357	704	614	439
TTM Free Cash Flow to Firm	324	427	321	320	465	626	640	811	755	1,290	690	547	933	836	668

Multiples (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	2.62	1.93	3.22	3.78	2.09	1.8	2.61	1.69	2.8	1.65	3.54	3.45	1.92	3.17	3.16
EV/EBIT	5.84	5.8	6.91	7.93	9.78	12.15	11.08	10.48	12.75	11.35	9.81	47.6	23.41	19.79	14.85
Enterprise Value	2,116	2,181	2,341	2,608	3,266	3,642	3,942	4,375	6,017	6,445	7,005	6,891	6,257	5,309	4,994
Low Price	2.95	3.74	3.88	5.47	5.42	3.95	6.46	7.98	6.98	5.39	13.8	10.16	11.46	12.42	11.65
EV/Sales	0.75	0.74	0.79	0.85	0.87	0.86	0.9	0.86	1.1	1.17	1.13	1.49	1.3	1.02	0.92
EV/EBITDA	4.88	4.97	5.81	6.56	7.44	8.18	7.64	7.07	8.79	8.33	7.64	19.65	13.15	11.24	10.48
Price/Earnings	6.38	4.76	7.48	8.3	6.25	7.91	6.92	8.12	11.37	7.47	5.13	10.3	6.4	10.97	12.46
Price/Earnings Average	5.97	4.86	5.65	7.72	7.19	7.01	6.1	9.63	8.03	5.39	6	10.24	7.36	10.23	12.85
Price/Earnings High	7.26	7.51	7.66	9.32	9.03	8.53	7.75	11.44	11.46	7.72	7.6	12.78	9.13	12.85	17.47
Price/Earnings Low	4.12	3.5	4.64	5.85	5.28	4.37	4.7	7.83	6.32	2.7	4.47	7.83	5.79	7.23	9.77
Price/Book Value	2.11	2.9	2.75	3.07	1.88	2.45	3.41	3.49	6.03	3.49	3.47	2.82	2.07	3.05	2.18
Price/Book Value Average	1.98	2.96	2.08	2.86	2.16	2.18	3.01	4.14	4.26	2.52	4.07	2.8	2.38	2.84	2.24
Price/Book Value High	2.4	4.57	2.81	3.45	2.72	2.65	3.82	4.92	6.07	3.61	5.15	3.5	2.95	3.57	3.05
Price/Book Value Low	1.36	2.13	1.7	2.17	1.59	1.36	2.31	3.37	3.35	1.26	3.03	2.14	1.88	2.01	1.71
Price/Tangible Book Value	-0.8	-0.73	-0.95	-1.07	-0.47	-0.42	-0.56	-0.39	-0.59	-0.91	-0.84	-0.67	-1.91	-5.36	-4.28
Price/Tangible Book Value Average	-0.75	-0.74	-0.72	-0.99	-0.55	-0.37	-0.5	-0.47	-0.42	-0.66	-0.98	-0.67	-2.2	-5	-4.41
Price/Tangible Book Value High	-0.91	-1.15	-0.98	-1.2	-0.68	-0.45	-0.63	-0.55	-0.59	-0.95	-1.24	-0.83	-2.73	-6.28	-6
Price/Tangible Book Value Low	-0.52	-0.54	-0.59	-0.75	-0.4	-0.23	-0.38	-0.38	-0.33	-0.33	-0.73	-0.51	-1.73	-3.53	-3.35
Price/Sales	0.25	0.24	0.29	0.33	0.22	0.22	0.28	0.22	0.31	0.35	0.33	0.36	0.32	0.45	0.33
Price/Sales Average	0.23	0.24	0.22	0.3	0.25	0.19	0.25	0.26	0.22	0.25	0.39	0.35	0.37	0.42	0.34
Price/Sales High	0.28	0.38	0.29	0.37	0.32	0.23	0.31	0.31	0.31	0.36	0.49	0.44	0.46	0.53	0.47
Price/Sales Low	0.16	0.18	0.18	0.23	0.18	0.12	0.19	0.21	0.17	0.13	0.29	0.27	0.29	0.3	0.26
Price/Cash Flow	3.17	2.36	4.44	5.87	3.92	2.63	5.15	2.26	3.79	1.88	5.14	5.75	2.68	4.54	5.26
Price/Cash Flow Average	2.97	2.41	3.36	5.46	4.51	2.34	4.54	2.69	2.68	1.36	6.01	5.72	3.08	4.23	5.42
Price/Cash Flow High	3.6	3.73	4.55	6.59	5.66	2.84	5.77	3.19	3.82	1.95	7.62	7.14	3.82	5.31	7.37
Price/Cash Flow Low	2.04	1.74	2.76	4.14	3.32	1.46	3.5	2.18	2.11	0.68	4.48	4.37	2.42	2.99	4.12
Price/Free Cash Flow Average	2.45	1.97	2.43	3.51	2.41	1.59	2.3	2.01	1.98	1.19	4.15	3.43	2.21	2.96	3.26
Price/Free Cash Flow High	2.98	3.04	3.3	4.24	3.03	1.94	2.92	2.38	2.82	1.7	5.26	4.28	2.74	3.72	4.44
Price/Free Cash Flow Low	1.69	1.42	2	2.66	1.77	0.99	1.77	1.63	1.56	0.6	3.09	2.62	1.74	2.09	2.48
EV/Sales Average	0.74	0.74	0.72	0.83	0.91	0.84	0.87	0.9	1.01	1.07	1.19	1.51	1.36	0.99	0.93
EV/Sales High	0.79	0.88	0.79	0.89	0.97	0.88	0.94	0.95	1.11	1.18	1.29	1.6	1.45	1.1	1.05
EV/Sales Low	0.67	0.68	0.68	0.75	0.84	0.77	0.81	0.85	0.97	0.94	1.09	1.43	1.28	0.87	0.84
EV/EBITDA Average	4.78	5	5.29	6.39	7.72	7.95	7.36	7.41	8.06	7.64	8.03	19.84	13.76	10.9	10.6
EV/EBITDA High	5.1	5.9	5.86	6.87	8.27	8.34	7.93	7.81	8.81	8.42	8.73	20.99	14.66	12.09	12.02
EV/EBITDA Low	4.32	4.54	5	5.82	7.15	7.27	6.88	7.01	7.69	6.74	7.36	18.75	12.96	9.55	9.66
EV/EBIT Average	5.72	5.84	6.29	7.71	10.14	11.8	10.67	10.98	11.7	10.41	10.31	48.05	24.51	19.19	15.02
EV/EBIT High	6.11	6.89	6.97	8.3	10.86	12.39	11.49	11.58	12.78	11.47	11.21	50.84	26.12	21.28	17.04
EV/EBIT Low	5.17	5.31	5.95	7.03	9.4	10.79	9.97	10.39	11.16	9.18	9.44	45.4	23.08	16.8	13.69
Last Price	4.57	5.08	6.25	7.76	6.41	7.14	9.51	8.27	12.57	14.9	15.83	13.37	12.66	18.85	14.85
High Price	5.2	8.02	6.4	8.71	9.26	7.7	10.65	11.66	12.66	15.41	23.48	16.59	18.05	22.07	20.83
Enterprise Value Average	2,072	2,197	2,132	2,538	3,390	3,539	3,798	4,584	5,520	5,908	7,356	6,956	6,550	5,149	5,051
Enterprise Value High	2,211	2,589	2,362	2,731	3,630	3,714	4,089	4,834	6,029	6,511	8,001	7,360	6,980	5,711	5,727
Enterprise Value Low	1,872	1,995	2,017	2,313	3,140	3,234	3,549	4,336	5,266	5,211	6,740	6,572	6,168	4,508	4,601

Shares Outstanding	145	141	140	131	131	133	134	135	134	135	134	127	128	129	124
Diluted Weighted Avg Shares	151	139	137	129	128	128	129	135	134	130	130	123	123	125	123
Basic Weighted Avg Shares	151	139	137	129	127	128	129	135	134	130	130	123	123	125	123
Revenue per Share	18.63	21.25	21.74	23.76	29.36	33	33.85	37.56	40.6	42.62	47.64	37.62	39.2	41.63	44.46
EBITDA per Share	2.88	3.17	2.95	3.08	3.44	3.48	4	4.58	5.1	5.96	7.04	2.86	3.87	3.79	3.88
Operating Income per Share	2.41	2.71	2.48	2.55	2.62	2.35	2.76	3.08	3.51	4.37	5.48	1.18	2.17	2.15	2.74
Basic EPS, GAAP	0.72	1.07	0.84	0.93	1.03	0.9	1.37	1.02	1.11	2	3.09	1.3	1.98	1.72	1.19
Basic EPS from Cont Ops	0.75	1.11	0.9	0.99	1.07	0.98	1.71	1.31	1.5	2.66	3.84	0.15	0.9	1.04	1.75
Diluted EPS, GAAP	0.72	1.07	0.83	0.93	1.02	0.9	1.37	1.02	1.11	2	3.09	1.3	1.98	1.72	1.19
Diluted EPS from Cont Ops	0.75	1.11	0.9	0.99	1.06	0.98	1.71	1.31	1.5	2.66	3.84	0.15	0.9	1.04	1.75
Dividend per Share	- -	1.52	0.31	0.41	0.1	- -	- -	- -	- -	- -	0.39	0.53	0.52	0.52	0.26
Cash Flow per Share	1.44	2.15	1.41	1.32	1.63	2.71	1.85	3.65	3.31	7.92	3.08	2.32	4.73	4.16	2.82
Free Cash Flow per Basic Share	1.14	1.66	0.87	0.58	0.2	1.45	0.04	2.42	2.14	6.79	1.69	0.77	2.87	2.37	0.96
Cash & Equivalents per Share	0.08	0.29	0.03	0.03	0.11	0.77	0.95	1.3	2.5	4.45	0.57	1.41	0.91	0.48	0.22
Book Value per Share	2.17	1.75	2.28	2.53	3.41	2.91	2.79	2.37	2.08	4.26	4.56	4.74	6.11	6.18	6.83
Tangible Book Value per Share	-5.7	-6.97	-6.55	-7.28	-13.53	-17.1	-16.88	-21.01	-21.38	-16.3	-18.88	-19.96	-6.62	-3.51	-3.47

Select Medical Holdings Corporation

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)